Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs target specific subsets of cancer, and we seek to simultaneously develop, with partners, companion diagnostics that direct our product candidates to the patients most likely to benefit from their use. We believe this approach to personalized medicine –
Rociletinib oral presentation on Sunday, May 31 to update TIGER-X
clinical data in heavily pretreated, advanced EGFR-mutant lung cancer
patients, including in plasma-genotyped T790M-positive patients
Rucaparib oral presentation on Monday, June 1 to include outcomes
data from full ARIEL2 part one population of ~200 women with advanced
Rociletinib rolling NDA submission for EGFR-mutant lung cancer
Rociletinib (CO-1686) rolling NDA submission for EGFR-mutant lung
cancer expected to commence in June, and complete by July/August
Launch planning underway for potential late 2015 U.S. launch of
Phase 1/2 rociletinib data published in April 30 issue of the New
England Journal of Medicine
Rucaparib granted Breakthrough Therapy designation in April
NDA filing f...
BOULDER, Colo.--(BUSINESS WIRE)--Apr. 23, 2015--
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter
2015 financial results on Wednesday, May 6, 2015, after the close of the
U.S. financial markets. Clovis’ senior management will host a conference
call and live audio webcast at 4:30 p.m. ET that day to discuss the
company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Sign up to receive email alerts whenever Clovis Oncology, Inc. posts new information to the site. Just enter your email address and click Submit.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.